Leucadia National Corp. (LUK) Falls 2.56% for February 05

Equities Staff |

One of the S&P 500’s big losers for Friday February 05 was Leucadia National Corp. (LUK). The company’s stock fell 2.56% to $15.99 on volume of 1.99 million shares.

The stock opened the day at 16.37 and traded between a low of $15.87 and a high of $16.40. The stock finished the day down $0.42 per share. Leucadia National Corp. has an average daily volume of 2.66 million and a total float of 362.34 million shares. The 50-day SMA for Leucadia National Corp. is $16.82 and its 200-day SMA is $20.84. The high for the stock over the last 52 weeks is $25.39 and the low is $15.20.

Leucadia National Corp through its subsidiaries is engaged in investment banking and capital markets, beef processing, manufacturing, energy projects, asset management and real estate.

Leucadia National Corp. is centered in New York, NY, and has 13,082 employees. Today’s trading day leaves the company with a market cap of $5.79 billion. The company has a P/S ratio of n/a, P/B ratio of 0.56, and a -4.

For a complete fundamental analysis analysis of Leucadia National Corp., check out Equities.com’s Stock Valuation Analysis report for LUK. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Propanc Health Group Corp

Propanc Health Group Corp is an early stage healthcare company. It is engaged in developing new cancer treatments for patients, suffering from pancreatic and colorectal cancer.

Private Markets

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…


Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.